MarketsStocksNOVELIX
NO

Novelix Pharmaceuticals Ltd

NSE: NOVELIXBSE: 536565Healthcare
Download Research Report7-page PDF
67.80
+3.51%
NSE · auto-updates while market open
Mkt Cap
₹142 Cr
P / E
55.3
P / B
3.0
ROE
8.0%
52W High
₹70.80
52W Low
₹27.94
Key Metrics
Market Cap
₹142 Cr
P / E
55.32
P / B
3.04
EV / EBITDA
40.16
ROCE
9.9%
ROE
8.0%
Debt / Equity
0.09
Book Value
₹22.05
EPS
₹1.21
Div Yield
0.0%
Face Value
-
Promoter Holding
49.4%
Revenue · ₹ Cr
31
FY18
10
FY19
10
FY20
9
FY21
1
FY23
31
FY25
132
FY26
Net Profit · ₹ Cr
2
0
0
3
0
0
-4
FY18FY19FY20FY21FY23FY25FY26
EPS · ₹ per share
₹0.1
₹0.1
₹1.2
₹-0.0
₹-0.3
₹-4.6
₹-0.1
FY16FY19FY20FY21FY23FY25FY26
Q3 2022 snapshot
Sales
₹1 Cr
Operating profit
₹-0 Cr
OPM
-14.1%
Net profit
₹-0 Cr
EPS
₹-0.19
Scorecard · 7 axes
Quality
Good
73/100
Valuation
Weak
55.3×
Growth
Strong
+58.3%
Profitability
Weak
9.0%
Performance
Strong
+134.4%
Entry Point
Bad
96%
Red Flags
Strong
0 flags
Shareholding Pattern
49.4%Promoter
Promoter49.4%
Public50.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue5.320.8622.3536.3948.425.19
Net Profit0.1480.1830.1070.5331.0040.912
NPM %2.8%0.9%0.5%1.5%2.1%3.6%
AlertPre-trade